M Khalid, S Andreoli - Pediatric Nephrology, 2019 - Springer
Hemolytic uremic syndrome is commonly caused by Shiga toxin-producing Escherichia coli (STEC). Up to 15% of individuals with STEC-associated hemorrhagic diarrhea develop …
Shigella species and Shiga toxin-producing Escherichia coli (STEC) are agents of bloody diarrhea that may progress to potentially lethal complications such as diarrhea-associated …
L Pape, H Hartmann, FC Bange, S Suerbaum… - Medicine, 2015 - journals.lww.com
Eculizumab in Typical Hemolytic Uremic Syndrome (HUS) With N... : Medicine Eculizumab in Typical Hemolytic Uremic Syndrome (HUS) With Neurological Involvement : Medicine Log in …
S Loos, W Aulbert, B Hoppe… - Clinical Infectious …, 2017 - academic.oup.com
Abstract Background. In 2011 Escherichia coli O104: H4 caused an outbreak with> 800 cases of hemolytic uremic syndrome (HUS) in Germany, including 90 children. Data on the …
Atypical hemolytic uremic syndrome is a thrombotic microangiopathy characterized by hemolysis, thrombocytopenia, and acute kidney injury, usually caused by alternative …
Hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenia purpura (TTP) are rare diseases sharing a common pathological feature, thrombotic microangiopathy (TMA). TMA is …
VJ Harkins, DA McAllister, BC Reynolds - Current Pediatrics Reports, 2020 - Springer
Abstract Purpose of Review We review the pathophysiology of Shiga-Toxin Enteropathogenic–Hemolytic Uremic Syndrome (STEC-HUS), strategies to ameliorate or …
H Ko, H Maymani, C Rojas-Hernandez - Journal of Medical Case Reports, 2016 - Springer
Background Hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli O157: H7 has been widely known as a common cause of acute renal failure in children …
Background Eculizumab for the treatment of atypical hemolytic uremic syndrome (HUS) is a standard of care. Central nervous system (CNS) involvement in Shiga toxin–producing …